申请人:A. Nattermann & Cie GmbH
公开号:US04654358A1
公开(公告)日:1987-03-31
The invention is related to imidazol-2-yl mercapto alkanoic acids having the formula I ##STR1## process for the treatment of humans suffering from inflammatory diseases or diseases in relation with the lipid metabolism.
本发明涉及具有公式I的咪唑-2-基巯基烷酸,其过程用于治疗患有炎症性疾病或与脂质代谢有关的疾病的人类。